Grass pollen allergy immunotherapy (Stallergenes Greer)

青草花粉过敏免疫疗法

Report date: 2022/01/14 13:23:58

Base Information

Drug NameGrass pollen allergy immunotherapy (Stallergenes Greer)
Drug Alias NameFive-grass pollen immunotherapy300 IR grass pollen allergen extractOralair GrassesOralair300-IR-SLIT +[6
ClassificationBiologics > Antigen > Allergen extract
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsHypersensitivityRhinitis, Allergic, SeasonalRhinitis, Allergic
Global Approved IndicationsRhinitis, Allergic, Seasonal
Approved Indications in ChinaN/A
Original Approved Country/TerritoryGermany
Original Approved Date2008/09/01
Country/TerritoryCzechiaUnited StatesPoland +[9
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesStallergenes Greer
China Registration ClassN/A

Develop Information

Active CompaniesAlk-Abelló A/S
Inactive CompaniesStallergenes Greer
Active IndicationsHypersensitivityRhinitis, Allergic, Seasonal
Inactive IndicationsRhinitis, Allergic

Other Information

ATC CodeV01AA02
Related LinksWikipedia